ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma
Phase 3
Not yet recruiting
- Conditions
- Scleroderma, Diffuse
- Interventions
- Device: ADRCsOther: Standard CareOther: Placebo
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Paracrine, INC.
- Target Recruit Count
- 174
- Registration Number
- NCT05148598
Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers
Phase 3
Not yet recruiting
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Device: ADRCsOther: standard careOther: Placebo
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Paracrine, INC.
- Target Recruit Count
- 290
- Registration Number
- NCT05095389
© Copyright 2025. All Rights Reserved by MedPath